177 related articles for article (PubMed ID: 10193729)
1. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
Szczeklik A; Musiał J; Undas A; Gajewski P; Góra P; Swadźba J; Jankowski M
J Am Coll Cardiol; 1999 Apr; 33(5):1286-93. PubMed ID: 10193729
[TBL] [Abstract][Full Text] [Related]
2. Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels.
Musiał J; Undas A; Undas R; Brozek J; Szczeklik A
Thromb Haemost; 2001 Feb; 85(2):221-5. PubMed ID: 11246536
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.
Szczeklik A; Musial J; Undas A; Swadzba J; Gora PF; Piwowarska W; Duplaga M
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):948-54. PubMed ID: 8696958
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin administration reduces thromboxane production in subjects taking aspirin: links between aspirin resistance and thrombin generation.
Undas A; Siudak Z; Topór-Mądry R; Leśniak M; Tracz W
Int J Cardiol; 2012 Jan; 154(1):59-64. PubMed ID: 21035882
[TBL] [Abstract][Full Text] [Related]
5. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation.
Undas A; Brummel KE; Musial J; Mann KG; Szczeklik A
Circulation; 2001 May; 103(18):2248-53. PubMed ID: 11342472
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
Sebestjen M; Boh M; Keber I
Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic actions of statins.
Szczeklik A; Undas A; Musial J; Gajewski P; Swadzba J; Jankowski M
Med Sci Monit; 2001; 7(6):1381-5. PubMed ID: 11687759
[TBL] [Abstract][Full Text] [Related]
9. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment with a commercially available St John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin.
Eggertsen R; Andreasson A; Andrén L
Scand J Prim Health Care; 2007 Sep; 25(3):154-9. PubMed ID: 17846933
[TBL] [Abstract][Full Text] [Related]
11. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor +5466A>G polymorphism determines thrombin formation following vascular injury and thrombin-lowering effects of simvastatin in patients with ischemic heart disease.
Undas A; Stepien E; Potaczek DP; Tracz W
Atherosclerosis; 2009 Jun; 204(2):567-72. PubMed ID: 19027114
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD
Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin decreases concentration of interleukin-2 in hypercholesterolemic patients after treatment for 12 weeks.
Zubelewicz-Szkodzińska B; Szkodziński J; Romanowski W; Błazelonis A; Danikiewicz A; Muc-Wierzgoń M; Szkilnik R
J Biol Regul Homeost Agents; 2004; 18(3-4):295-301. PubMed ID: 15786696
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
De Caterina R; Cipollone F; Filardo FP; Zimarino M; Bernini W; Lazzerini G; Bucciarelli T; Falco A; Marchesani P; Muraro R; Mezzetti A; Ciabattoni G
Circulation; 2002 Nov; 106(20):2543-9. PubMed ID: 12427649
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
17. Effect of moderate and high-dose simvastatin on asymmetric dimethylarginine-homocysteine metabolic pathways in patients with newly detected severe hypercholesterolemia.
Vladimirova-Kitova LG; Deneva TI; Marinov B
Cardiovasc Ther; 2011 Oct; 29(5):340-8. PubMed ID: 20345493
[TBL] [Abstract][Full Text] [Related]
18. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
